跳至主要内容
临床试验/EUCTR2013-000970-31-DE
EUCTR2013-000970-31-DE进行中(未招募)1 期

Randomized, placebo-controlled multicenter trial of lithium plus treatment asusual (TAU) for acute suicidal ideation and behaviour in patients with suicidalmajor depressive episode - Lithium

Technische Universität Dresden0 个研究点目标入组 254 人开始时间: 2013年10月1日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
254

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Diagnosis of a major depressive episode; inpatient at screening visit; suicidal
  • ideation/behaviour present defined by a clinical rating of = 8 on the Sheehan
  • Suicidality Tracking Scale (S-STS) at screening visit and a rating of =20 on the Montgomery
  • Asberg Depression Scale (MADRS) at both screening and baseline visits; both
  • gender, age = 18 years.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 200
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 54

排除标准

  • Contraindication for and history of lithium treatment within the past 6 months;
  • patient unable to tolerate lithium treatment in the past; comorbid
  • borderline/antisocial personality disorder, currently active substance
  • dependency; patients with acute or unstable severe medical conditions, patients
  • unable to understand the informed consent or involuntary inpatients, drug dependence (according to ICD10 or DSMIV and positive Diagnose in MINI), pregnancy and lactation

研究者

相似试验

Randomized, placebo-controlled multicenter trial of... | 临床试验